FDA Hot Topics

This session is dedicated to FDA regulation of digital health products, from traditional software-based medical devices to novel medical device software functions deployed on consumer products or wearables. Participants will join FDA leaders in a discussion about expectations for implementing artificial intelligence/machine learning, Predetermined Change Control Plans (PCCPs), and other digital health guidance or policy updates